ANN ARBOR, Mich., – December 4, 2017- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that it has expanded research operations at its new Michigan facility with the appointment of a new lead molecular biologist. In this role he will play a key part in developing the next generation of recombinant silk fibers and protein constructions as well as overseeing all aspects of our research laboratory. Over the next 60 days the Company plans to hire additional research staff to support this role as the Company rapidly ramps up development of new and stronger transgenics and polymers.
“After reviewing and screening numerous candidates for this crucial role, I am confident that we’ve found an ideal match,” said Jon Rice, COO. “With excellent technical skills and a great cultural fit, he is already well on the way to making significant contributions to the team and our technology. We expect great things from him over the coming quarter and I look forward to sharing those results with all of the Kraig Labs shareholders.”
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC